A growing body of evidence points towards the involvement of cathepsins in multiple processes related to the pathology of NASH and hallmarks of cancer, suggesting that cathepsins can be used as a promising diagnostic tool and therapeutic target for NASH-HCC. Here, CTSS is linked to hepatocellular carcinoma.